Research shows that CBD can be used to decrease the frequency of seizures without the psychoactive properties of medical cannabis.

The World Health Organisation (WHO) announced that there medicinal and therapeutic benefits of cannabidiol (CBD) and one of the pathologies which can be treated is epilepsy.

Epilepsy is when two or more unprovoked and unexpected seizures arise. Seizures are brief episodes of involuntary movement that may involve the entire body (generalized) or a part of the body (partial).

Medically, refractory epilepsy remains an area of scientific interest as up to 35% of patients continue to suffer from seizures despite current therapies. Recent evidence has focused on the benefit of cannabidiol (CBD), a marijuana plant-based product with no psychoactive properties, can be used to decrease seizure frequency.

Medical Research with Oral CBD

In 2019, a group of researchers analysed several published articles of this pure oral CBD extract as an additional therapy for treating refractory epilepsy, Lennox-Gastaut and Dravet syndromes, convulsive seizures decrease by 50%. Additionally, in patients with treatment-resistant epilepsy of multiple aetiologies, similar benefits were observed.

Furthermore, a stopped/decreased dose of anti-seizure medication was observed when taking the CBD oil.

The therapeutic potential of CBD in epilepsy exists, however, further studies are still needed to better understand the full mechanism of action.

Source:

https://www.kalapa-clinic.com/en/new-stance-cbd-who/